BMP15

protein-coding

bone morphogenetic protein 15, the group of Bone morphogenetic proteins

Gene summary

This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate subunits of a disulfide-linked homodimer, or alternatively, a heterodimer, with the related protein, growth differentiation factor 9 (GDF9). This protein plays a role in oocyte maturation and follicular development, through activation of granulosa cells. Defects in this gene are the cause of ovarian dysgenesis and are associated with premature ovarian failure. [provided by RefSeq, Aug 2016]

MANE transcript

NM_005448.2

Inheritance

AD, XL

ClinVar variants

P:12U:53B:17

Top phenotype

Ovarian dysgenesis 2

gnomAD constraint

pLI —, LoF o/e 0.68

Max pathogenic AF

—

Genomic locus

chrX:50,910,735-50,916,641

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~5.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

ovarian dysgenesis 2MODERATE

Inheritance Pattern: AD

Disease ID:MONDO:0010349

Submitter: Ambry Genetics

ovarian dysgenesis 2MODERATE

Inheritance Pattern: XL

Disease ID:MONDO:0010349

Submitter: Ambry Genetics

46 XX gonadal dysgenesisSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0009299

Submitter: Orphanet

ovarian dysgenesis 2STRONG

Inheritance Pattern: XL

Disease ID:MONDO:0010349

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Ovarian dysgenesis 2XL

Manifestation: Endocrine; Genitourinary; Obstetric

Intervention: Obstetric

Rationale: Genetic knowledge may allow reproductive capabilities such as via egg preservation

Refs: 15136966; 16508750; 19263482Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to BMP15 variants in ClinVar

8 Conditions Cataloged
Inborn genetic diseasesTotal: 41
Ovarian dysgenesis 2Total: 25
not providedTotal: 18
BMP15-related disorderTotal: 6
not specifiedTotal: 6
Premature ovarian failure 4Total: 4
Genetic non-acquired premature ovarian failureTotal: 2
Hereditary pancreatitisTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_005448.2. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
1
clinvar
5
missense
5
clinvar
3
clinvar
52
clinvar
11
clinvar
1
clinvar
72
nonsense
2
clinvar
1
clinvar
3
start loss
0
frameshift
1
clinvar
1
clinvar
2
splice donor/acceptor (+/-2bp)
0
Total755315282

Highest pathogenic variant AF is 0.00019167423

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 2 of 2 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_005448.2RefSeqNP_005439.22MANE Select
ENST00000252677.4EnsemblENSP00000252677.32MANE Select

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
bmp15Danio rerio

Structure: ovarian follicle

Quality: maturity

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Ovarian steroidogenesis - Homo sapiens (human)
  • TGF-Core
  • Post-translational protein phosphorylation
  • Post-translational protein modification
  • Metabolism of proteins

Biological Process

  • ovarian follicle development
  • female gamete generation
  • regulation of signaling receptor activity
  • positive regulation of pathway-restricted SMAD protein phosphorylation
  • BMP signaling pathway

Molecular Function

  • cytokine activity
  • transforming growth factor beta receptor binding
  • growth factor activity

Cellular Component

  • extracellular space
  • endoplasmic reticulum lumen

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000252677
Coding exons
2
Length
5824
Individuals with no LoFs
125707
Homozygous LoFs
4
Heterozygous LoFs
11
Defined
125722
p
0.0000597
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.06991571590.9840.00001272547
Missense (PolyPhen)3436.9630.91984606
Synonymous0.06095656.60.9900.00000405794
Loss of Function0.948710.30.6818.83e-7143

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000150.00012rare
Latino/Admixed American0.0000360.000029rare
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)0.000140.000097rare
South Asian0.0000520.000033rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: May be involved in follicular development. Oocyte- specific growth/differentiation factor that stimulates folliculogenesis and granulosa cell (GC) growth. {ECO:0000269|PubMed:18227435}.;
Disease
DISEASE: Ovarian dysgenesis 2 (ODG2) [MIM:300510]: A disorder characterized by lack of spontaneous pubertal development, primary amenorrhea, uterine hypoplasia, and hypergonadotropic hypogonadism as a result of streak gonads. {ECO:0000269|PubMed:15136966}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Premature ovarian failure 4 (POF4) [MIM:300510]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:16464940, ECO:0000269|PubMed:16508750, ECO:0000269|PubMed:16645022, ECO:0000269|PubMed:19263482, ECO:0000269|PubMed:19438907}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.191

Intolerance Scores

LoFtool
0.215
RVIS EVS
0.6
RVIS percentile EVS
82.66

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.223

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.